ISPO

predictive markers

Expression of human uroplakin-Ia in urinary bladder transitional cell carcinoma and its clinical implication

S Kageyama MD , T Yoshiki PhD , T Yuasa PhD , T Isono PhD , T Tanaka PhD , Y Okada PhD

Cytokines in melanoma patients: possible predictive markers?

S Moretti MD , A Chiarugi MD , A Salvi DSc , M Fabiani DSc , P Fabbri MD , S Mazzoli PhD

MUC2 in clear cell carcinoma of the ovary

K Fujii MD, T Kita MD, H Nakata MD, M Takano MD, K Yamamoto MD, J Hirata PhD, Y Kikuchi MD, I Nagata MD

Evaluation of the usefulness of serum anti-p53 antibodies detection in patients with ulcerative colitis classified negative for dysplasia

M Cioffi MD , G Riegler MD , MT Vietri MD , P Gazzerro , L Caserta , A D’Auria MD , R Carratù MD , GA Puca MD , AM Molinari MD

Interferon-γ and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma

M Royuela PhD , MP de Miguel PhD , MI Arenas PhD , B Fraile PhD , FR Bethencourt MD , R Vera MD , E Romo PhD , R Paniagua PhD

The efficacy of serum concentration of carboxyterminal pyridinoline cross-linked telopeptide of type 1 collagen for the screening as a quantitative marker of bone metastases in patients with urological malignancies

T Okamura MD , H Tatsura MD , N Kawai MD , M Azemoto MD , D Nagata , K Kohri MD

Comparative genomic hybridization and loss of heterozygosity studies in esophageal squamous cell carcinoma in South Africa: Identification of a novel locus on 4p and two distinct loci on 8p

L DuPlessis MSc , MJ Kotze PhD

ELISA-based serological testing for the differential diagnosis of nasopharyngeal carcinoma among Ear, Nose and Throat department outpatients

TTM Tan MSc, YH Goh MBBS , WK Low MBBS , SY Tsao MBBS , LH Gan PhD , YY Gan PhD

c-erbB-2 overexpression identifies a subset of estrogen receptor positive (ER+) breast cancer patients with poor clinical outcome

AE Pinto MD, S André MD, T Pereira HT, J Soares MD PhD

Predictive molecular biomarkers induced by radiation exposure: Application to radiation carcinogenesis and cancer chemoprevention

AC Miller PhD, EJ Ainsworth PhD, TS Seed

Expression of the translation initiation factor eIF-4E in colon cancer

J Berkel MD PhD , E Turbat-Herrera MD , R Shi MD MPH PhD , A deBenedetti PhD

Effect of chronic hypoxia on sensitivity to radiation and cddp/5-fu/folinique ac treatment in a squamous cell carcinoma cell line (kb-3-1)

O Cuisnier MD , J Balosso MD PhD , E Reyt MD , X Leverve MD PhD , C Riva PhD

Relationship between the telomerase activity and Helicobacter pylori infection in the gastric carcinogenesis

EH Lee MD, JY Kim MD , HR Moon MD , SS Kang MD

Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential usage for diagnosis

P Feng PhD , E Ren PhD , D Liu PhD , S Chan MD , H Hu PhD

Potential diagnostic significance of blood based RT-PCR assays of MN/CA9 and prostate specific membrane antigen

A de la Taille MD , Y Cho , A Shabsigh MD , AE Katz MD , J McKiernan MD , R Buttyan PhD , NH Bander MD , CA Olsson MD , IS Sawczuk MD

Prognostic factors in node-negative breast cancer

G Uemura MD , LA De Luca MD , P Traiman MD , JRP Rodrigues MD , TLR Pinaffi MD , J Nahas-Neto MD

Prediction of response to doxifluridine and capecitabine in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor

W Koizumi MD , K Saigenji MD , I Okayasu MD , M Kurihara MD

p53, bcl-2, and E-Cadherin expression as predictors of treatment failure after radical prostatectomy

JD Oxley MB BS , SF Brewster MD , M Winkler MB BS , C Abbott BSc , D Gillatt MB ChB

ICAM-1 and b3 integrin immunoexpression in malignant melanoma cells: can they be used as additional predictors?

K Aroni, KN Charitopoulos MD, EB Chatzigianni MD, AC Lazaris, N Kavantzas, S Tseleni-Balafouta, P Davaris

Is BAT quasi-monophormic tract a prognostic indicator for endometrial cancer?

YF Wong MD PhD, TH Cheung MD, TKH Chung MD

Overexpression of nm23 protein is correlated with good prognosis in pathologic stage I non-small cell lung carcinoma

H Oyanagi MD, H Katakura MD, F Tanaka MD, Y Otake MD, K Yanagihara PhD, M Omasa MD, T Takata MD, T Nakagawa MD, T Yamada MD, R Miyahara MD, K Matsuoka MD, T Shoji MD, Y Kawano MD, M Li MD, K Inui PhD, H Wada PhD

Alterations of expression and localization of integrin beta-4 in bladder cancer

T Harabayashi MD, N Shinohara MD, T Watanabe PhD, A Sazawa MD, K Haga MD, A Taniguichi MD, T Koyanagi MD

The use of flow cytometry and cytogenetic analysis in defining the lymphoma subtype

G Rymkiewicz, B Pienkowska-Grela, O Mioduszewska, J Rygier, B Grygalewicz, R Woroniecka, A Witkowska, L Poplawska-Szczyglowska, J Walewski

Evaluation of serum tumor markers in opisthorchiasis-associated cholangiocarcinoma

B Sripa PhD , V Bhudhisawasdi MD , S Wongkham PhD , C Pairojkul MD , U Cha-on MSc , O Saeseow MD , S Chua-in MD , A Puapairoj MD , J Kularbkaew MD , T Uttaravichien MBBS

Cytyc Thinprep* processing of urinary specimens for the evaluation of bladder neoplasms

E Piaton, J Faÿnel, MC Ranchin, K Hutin

Changes in cell metabolism following gamma and proton irradiation are revealed by 1H MR spectroscopy

L Guidoni PhD , S Grande PhD , R Cherubini PhD , AM Luciani PhD , A Rosi PhD , V Viti PhD

Dna cytometry in the therapy of patients with prostatic carcinoma and its clinical relevance

H Al-Abadi MD , H Abou-Rebyeh MD , V Bergmann MD , I Rotter CTIAC , R Nagel MD , P Neuhaus MD

DNA-analysis of cholangiocarcinoma cells: prognostic and clinical importance

H Abou-Rebyeh MD , H Al-Abadi MD , S Jonas MD , I Rotter CTIAC , WO Bechstein MD , P Neuhaus MD

Tumour marker CYFRA 21-1 in patients with cancer of the larynx (preliminary report)

MA Lachowicz MD , S Chodynicki MD